Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

The National Institutes Of Health's National Institute Of Allergy And Infectious Diseases Announced Topline Results From Preliminary Analysis Of PALM 007 Trial Of Tecovirimat For Monkeypox Virus. The Study Did Not Meet Its Primary Endpoint Of A Statistically Significant Improvement In Time To Lesion Resolution Within 28 Days Post-randomization For Patients In Congo Versus Placebo

Author: Benzinga Newsdesk | August 15, 2024 07:39am

Posted In: SIGA